KEMKES · registration AKL 20305520020Active

MAGLUMI<sup>®</sup> Anti-Cardiolipin IgM (CLIA)

Name: MAGLUMI ® Anti-Cardiolipin IgM (CLIA) — KEMKES AKL 20305520020
Creator: SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Keywords: MAGLUMI ® Anti-Cardiolipin IgM (CLIA), MAGLUMI ® Anti-Cardiolipin IgM (CLIA), AKL 20305520020, Invitro Diagnostik, KEMKES

IndonesiaInvitro DiagnostikClass BSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

Verified

Official record identity

KEMKES registration number: AKL 20305520020
Model name: Ref. No. 130217016M dan 130617016M
Registration date: January 09, 2025
Expiry date: August 13, 2029
Status: Active

Classification

Risk class: Class B
Published category: Invitro Diagnostik

Published parties

Registrant / registration holder: PT SNIBE DIAGNOSTIC INDONESIA
Manufacturer: SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Manufacturer country: China

Additional source fields

Registration scope: akl
Published category: Sistem Tes Imunologikal
Registrant address: TEMPO SCAN TOWER, LANTAI 21, JALAN H.R. RASUNA SAID KAV. 3-4
Registrant region: Kec. Grogol Petamburan, Kota Jakarta Barat, Prov. DKI Jakarta

About this record

This page mirrors one current AKD or AKL row from KEMKES’s official public registry. Registrant, manufacturer, model, related company, class, and validity retain their published roles. Source HTML fragments are decoded for display, while the complete raw JSON responses remain immutable evidence.